Middle East and Africa clinical trial imaging market Information, by Products (Services, Software, and others), by Modality (X-Ray, Ultrasound, CT, PET, MRI, Echocardiography, and others), by End Users (pharmaceutical companies, biotech companies, research centers, hospitals and others) - Forecast to 2027

 Market Synopsis of Middle East and Africa clinical trial imaging market:

Market Scenario:

Clinical trials are very important part of the extensive and expensive research and drug development process. Increasing costs for drug development, pharmaceutical and biotechnology companies are exploring innovative technologies and investing in R&D to develop new drugs to market sooner for unmet needs (e.g., rare diseases). Clinical trials can fuel by using imaging as a primary as well as quantitative biomarker. Finding best alternative outcome measures that can be observed soon after the therapy is given could reduce the cost of drug trials, and make effective therapies available to the public more quickly. In Middle East and Africa, number of cases of non-communicable diseases such as heart diseases, stroke, and diabetes are increasing. Huge funding in R&D and various initiatives by government are driving the growth for clinical trial imaging market in Middle East and Africa. Middle East and Africa clinical trial imaging market is increasing moderately. Clinical trial imaging market is growing at a CAGR of 6.1% and expected to reach US$ 115.6 million by 2022 which was US$ 76.1 million in 2015.

Study objectives of Middle East and Africa Clinical Trial Imaging Market:

• To provide detailed analysis of the market structure along with forecast for the next 5 years of the various segments and sub-segments of the Clinical Trial Imaging Market


• To provide insights about factors affecting the market growth


• To analyze the Middle East and Africa clinical trial imaging market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.


• To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries.


• To provide country level analysis of the market with respect to the current market size and future prospective


• To provide country level analysis of the market for segments by product, by modality, by end user, and its sub-segments.


• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market


• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle East and Africa clinical trial imaging market.

Key Players for Middle East and Africa clinical trial imaging market:   

Some of the key players in this market are: Bioclinica, Inc. (US), Cardiovascular Imaging Technologies, LLC (US), Parexel International Corporation (US), Biomedical Systems Corporation (US), Icon PLC (Republic of Ireland), Intrinsic Imaging LLC (US), Biotelemetry, Inc. (US), Intrinsic Imaging LLC (US), Parexel International Corporation (US).

Segments:      

Middle East and Africa clinical trial imaging market has been segmented on the basis of products which comprises Services, Software, and others. On the basis of modality, the market is segmented into X-Ray, Ultrasound, CT, PET, MRI, Echocardiography, and others. On the basis of end user, the market segmented into pharmaceutical companies, biotech companies, research centers, hospitals and others.

Regional Analysis of Middle East and Africa clinical trial imaging market:     

Considering the Middle-East and Africa Middle East and Africa clinical trial imaging market scenario, UAE region is believed to be the largest market for Middle East and Africa clinical trial imaging market. Moreover Saudi Arabia market is also growing and second largest market for clinical trial imaging market. On the other hand, Egypt market is expected to grow at the steady pace in the Middle East and Africa clinical trial imaging market during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market. The report for Middle East and Africa Clinical Trial Imaging Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions Intended Audience

• Clinical trial imaging equipment manufacturers


• Clinical trial imaging market equipment suppliers


• Contract Research Organizations (CROs)


• Research and Development (R&D) Companies


• Government Research Laboratories


• Independent Research Laboratories


• Government and Independent Regulatory Authorities


• Market Research and Consulting Service Providers


• Academic Institutes and Universities